Dr. Bellomo manages the Business Development and Technology Transfer of Ospedale San Raffaele’s research outputs in the field of biotech, med tech and digital health. She also supervises and promotes growth of technology transfer in other two Hospitals of San Donato Group: IRCCS Policlinico San Donato and IRCCS Galeazzi – Sant’ Ambrogio.

She is in charge of creation and portfolio management of San Raffaele’s start up companies and currently Board Member of San Raffaele’s spin offs Genenta and Genespire (as observer) in the gene therapy field.

She has been Board Member at Parco Tecnologico Padano and Board Member Observer of BiovelocITA as well as Advisor to several life science start up companies, venture capital, and incubators in the biotech and med tech field.

Previous experience includes: founder and managing director of TTFactor, the former joint tech transfer company of the European Institute of Oncology (IEO) and the Firc Institute for Molecular Oncology (IFOM); Head of Biotechnology Transfer Office at San Raffaele Hospital; Senior Business Development Officer for IMBcom (the former commercialization company of University of Queensland’s department of Molecular Bioscience); post doctoral fellow at the QIMR Berghofer Medical Research Institute.

She holds an MSc in Biology from the University of Milan; PhD from the University of London and an MBA from QUT in Brisbane, Australia. She is an italian and Australian citizen.

Daniela received the Rosa Camuna Prize from the Governor of the Region of Lombardy in 2011 for her social and scientific achievements.